AUTHOR=Cantero-Navarro Elena , Rayego-Mateos Sandra , Orejudo Macarena , Tejedor-Santamaria Lucía , Tejera-Muñoz Antonio , Sanz Ana Belén , Marquez-Exposito Laura , Marchant Vanessa , Santos-Sanchez Laura , Egido Jesús , Ortiz Alberto , Bellon Teresa , Rodrigues-Diez Raúl R. , Ruiz-Ortega Marta TITLE=Role of Macrophages and Related Cytokines in Kidney Disease JOURNAL=Frontiers in Medicine VOLUME=8 YEAR=2021 URL=https://www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2021.688060 DOI=10.3389/fmed.2021.688060 ISSN=2296-858X ABSTRACT=

Inflammation is a key characteristic of kidney disease, but this immune response is two-faced. In the acute phase of kidney injury, there is an activation of the immune cells to fight against the insult, contributing to kidney repair and regeneration. However, in chronic kidney diseases (CKD), immune cells that infiltrate the kidney play a deleterious role, actively participating in disease progression, and contributing to nephron loss and fibrosis. Importantly, CKD is a chronic inflammatory disease. In early CKD stages, patients present sub-clinical inflammation, activation of immune circulating cells and therefore, anti-inflammatory strategies have been proposed as a common therapeutic target for renal diseases. Recent studies have highlighted the plasticity of immune cells and the complexity of their functions. Among immune cells, monocytes/macrophages play an important role in all steps of kidney injury. However, the phenotype characterization between human and mice immune cells showed different markers; therefore the extrapolation of experimental studies in mice could not reflect human renal diseases. Here we will review the current information about the characteristics of different macrophage phenotypes, mainly focused on macrophage-related cytokines, with special attention to the chemokine CCL18, and its murine functional homolog CCL8, and the macrophage marker CD163, and their role in kidney pathology.